Will Buntanetap from Annovis Bio receive FDA approval before 2028?
Basic
9
Ṁ6252028
13%
chance
1D
1W
1M
ALL
The drug is in phase 3 trials now for Parkinson's Disease and Alzheimer's Disease.
AKA Posiphen or ANVS401
Study link here: https://clinicaltrials.gov/ct2/show/NCT05357989
This question is managed and resolved by Manifold.
Get
1,000
and3.00
Sort by:
Related questions
Related questions
Will AOH1996 be FDA approved before 2040?
44% chance
Will AOH1996 advance past Phase II trials by the end of 2027?
51% chance
Will an AI-designed drug get FDA approval by the end of 2025?
30% chance
Will a drug to be used by most healthy adults be approved by 2043 year end?
66% chance
Will a senolytic drug be used clinically for any purpose by the end of 2028?
58% chance
💊Will INS018_055 be FDA-approved by 2030?
48% chance
Will FDA approve any mRNA vaccine against melanoma before 2028?
49% chance
Will a novel therapeutic/device which confers a survival benefit for glioblastoma be FDA approved by EOY 2028?
51% chance
Will Immunovant agree to be acquired by the end of 2024?
22% chance
Will FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
43% chance